These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17966103)

  • 1. [Serum biomarkers in idiopathic pulmonary fibrosis].
    Ziora D
    Pneumonol Alergol Pol; 2007; 75(3):268-72. PubMed ID: 17966103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
    Yanaba K; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
    Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
    Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum biomarkers in idiopathic pulmonary fibrosis].
    Chudzicka A
    Pol Merkur Lekarski; 2010 Nov; 29(173):291-5. PubMed ID: 21268912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
    Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
    Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
    J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
    Huang H; Peng X; Nakajima J
    Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
    Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
    Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
    Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
    Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
    Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.
    Takahashi H; Shiratori M; Kanai A; Chiba H; Kuroki Y; Abe S
    Respirology; 2006 Jan; 11 Suppl():S51-4. PubMed ID: 16423272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
    Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
    Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung injury and serum markers].
    Suwabe A
    Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity tests for respiratory diseases--SP-A, SP-D, KL-6].
    Kambe M; Ohshimo S; Kohno N
    Rinsho Byori; 2007 Apr; 55(4):381-7. PubMed ID: 17511270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic pulmonary fibrosis: serum markers].
    Oshimo S; Kono N
    Nihon Naika Gakkai Zasshi; 2005 Jun; 94(6):1061-7. PubMed ID: 15997730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.